Complementary Dual Approach for In Silico Target Identification of Potential Pharmaceutical Compounds in Cystic Fibrosis by Liza Vinhoven, Frauke Stanke, Sylvia Hafkemeyer, Manuel Manfred Nietert

Get full text

CFTR Lifecycle Map—A Systems Medicine Model of CFTR Maturation to Predict Possible Active Compound Combinations by Liza Vinhoven, Frauke Stanke, Sylvia Hafkemeyer, Manuel Manfred Nietert

Get full text

Integrating Text Mining into the Curation of Disease Maps by Malte Voskamp, Liza Vinhoven, Frauke Stanke, Sylvia Hafkemeyer, Manuel Manfred Nietert

Get full text

Epidemiological trends in nontuberculous mycobacterial infection among people with cystic fibrosis in Germany by Mathis Steindor, Sylvia Hafkemeyer, Christian Ruckes, Florian Stehling, Lutz Naehrlich, Felix C Ringshausen

Get full text

Use of elexacaftor/tezacaftor/ivacaftor leads to changes in detection frequencies of Staphylococcus aureus and Pseudomonas aeruginosa dependent on age and lung function in people w... by Anna-Maria Dittrich, Sarah Sieber, Lutz Naehrlich, Manuel Burkhart, Sylvia Hafkemeyer, Burkhard Tümmler

Get full text

Molecular Epidemiology of Mycobacterium abscessus Isolates Recovered from German Cystic Fibrosis Patients by Nils Wetzstein, Margo Diricks, Thomas A. Kohl, Thomas A. Wichelhaus, Sönke Andres, Laura Paulowski, Carsten Schwarz, Astrid Lewin, Jan Kehrmann, Barbara C. Kahl, Karl Dichtl, Christian Hügel, Olaf Eickmeier, Christina Smaczny, Annika Schmidt, Stefan Zimmermann, Lutz Nährlich, Sylvia Hafkemeyer, Stefan Niemann, Florian P. Maurer, Michael Hogardt

Get full text